ACCEPTED MANUSCRIPT
10
Tetrahedron
1
Colorless powder. H NMR (300 MHz, CDCl3): δ = 2.19
128.3 (d, J = 12.3 Hz, CAr), 129.0 (CAr), 129.2 (CAr), 130.2 (q,
CAr), 131.2 (q, CAr), 131.8 (d, J = 2.9 Hz, CAr), 132.1 (d, J = 2.7
Hz, CAr), 132.2 (q, CAr), 132.5 (d, J = 11.5 Hz, CAr), 133.2 (d, J =
12.2 Hz, CAr), 138.4 (q, CAr), 150.6 (q, d, J = 19.2 Hz, CAr) ppm.
(3H, s, CH3), 4.50 (2H, s, CH2), 5.36 (2H, (d, J = 17.0 Hz, CH2),
6.33 (2H, d, J = 8.1 Hz, CHAr), 6.83 (2H, d, J = 8.0 Hz, CHAr),
7.12–7.53 (m, 20 H, CHAr), ppm. 13C NMR (75.5 MHz, CDCl3):
δ = 21.1 (CH3), 54.0 (CH2), 61.8 (CH2), 124.9 (q, CAr), 125.8 (q,
CAr), 127.5 (CAr), 128.1 (d, J = 12.2 Hz, CAr), 128.7 (CAr), 128.8
(d, J = 12.6 Hz, CAr), 129.2 (CAr), 130.3 (q, CAr), 130.8 (q, CAr),
131.8-132.0 (m, CAr), 132.1 (d, J = 12.0 Hz, CAr), 133.3 (d, J =
11.2 Hz, CAr), 138.4 (q, CAr), 150.9 (q, d, J = 18.0 Hz, CAr) ppm.
31P NMR (121.5 MHz, CDCl3): δ = -11.9 (dd, 1J(P2Pt) = 3726.8 Hz,
31P NMR (121.5 MHz, CDCl3): δ = 1.6 (d, J(PP) = 17.1 Hz),
2
2
120.6 (d, J(PP) = 17.8 Hz) ppm. MS (EI, 70 eV): m/z (%) = 342
(21.5) [M-Ph2PO-N2]+, 201 (40) [Ph2PO]+, 84 (100). HRMS
(ESI) for C35H31ClN3OP2Pd found: 712.0723 [M-Cl]+, cacld.
712.06698 [M-Cl]+.
2J(PP) = 15.0 Hz,), 91.2 (dd, J(PPt) = 3868.6 Hz, J(PP) = 15.0 Hz)
Acknowledgments
1
ppm. HRMS (ESI) for C35H31ClN3OP2Pt found: 802.12843 [M-
Cl]+, cacld. 802.12739[M-Cl]+.
The authors are grateful to by Evonik Oxeno GmbH for
financial support of this work. We thank Dr. C. Fischer, S.
Buchholz, A. Lehmann and K. Romeike (all at the Leibniz-
Institut für Katalyse e.V.) for their excellent analytical support.
4.11.3. Pt(8a)Cl2
Colorless powder. 1H NMR (300 MHz, CDCl3): δ = 4.73 (2H,
d, J = 8.4 Hz, CH2), 4.90 (2H, d, J = 7.8 Hz, CH2), 5.34 (2H, s,
CH2, CH2Ph), 6.95 (2H, d, J = 7.8 Hz, CHAr), 7.12-7.47 (m, 19 H,
CHAr), 7.61-7.70 (4H, m, CHAr) ppm. 13C NMR (75.5 MHz,
CDCl3): δ = 52.8 (CH2), 59.2 (d, J = 6.4 Hz, CH2), 60.8 (d, J =
7.3 Hz, CH2), 126.4 (CAr), 127.2 (d, J = 7.8 Hz, CAr), 127.4 (d, J
= 8.0 Hz, CAr), 127.7 (CAr), 127.8 (CAr), 128.1 (CAr), 129.4 (CAr),
129.6 (CAr), 130.2 (CAr), 130.3 (CAr), 130.4 (CAr), 130.6 (CAr),
131.0 (dd, J = 2.7 Hz, J = 12.0 Hz, CAr), 131.5 (d, J = 12.0 Hz,
CAr), 131.9 (d, J = 12.0 Hz, CAr), 132.7 (CAr), 142.5 (d, J = 8.8
Hz, CAr) ppm. 31P NMR (121.5 MHz, CDCl3): δ = 87.06 (dd,
1J(PPt) = 4187.9 Hz, 2J(PP) = 7.4 Hz,), 88.6 (dd, 1J(PPt) = 4216.9 Hz,
2J(PP) = 7.4 Hz) ppm. HRMS (ESI) for C35H31ClN3O2P2Pt found:
818.11312 [M-Cl]+, cacld. 818.11772 [M-Cl]+.
References and notes
1. Phosphorus(III) Ligands in Homogeneous Catalysis, Design and
Synthesis, P. C. J. Kamer, P. W. N. M. van Leeuwen (Eds.),
Wiley-VCH, 2012.
2. a) H. C. Kolb, M. G. Finn, B. K. Sharpless, Angew.Chem. Int. Ed.
2001, 40, 2004-2021; b) H. C. Kolb, B. K. Sharpless, Drug
Discovery Today 2003, 8, 1128-1137.
3. a) V. V. Rostovtsev, L. G. Green, V. V. Fokin, K. B. Sharpless,
Angew. Chem. Int. Ed. 2002, 41, 2596-2599; b) C. W. Tornøe, C.
Christensen, M. Meldal, J. Org. Chem. 2002, 67, 3057-3064; c) L.
V. Lee, M. L. Mitchell, S.-J. Huang, V. V. Fokin, K. B. Sharpless,
C.-H. Wong, J. Am. Chem. Soc. 2003, 125, 9588-9589; d) S. G.
Agalave, S. R. Maujan, V. S. Pore, Chem. Asian J. 2011, 6, 2696-
2718.
4. a) D. Liu, W. Gao, Q. Dai, X. Zhang, Org. Lett. 2005, 4907-4910;
b) Q. Dai, W. Gai, D. Liu, L. M. Kapes, X. Zhang, J. Org. Chem.
2006, 71, 3928-3934.
5. S.-i. Fukuzawa, H. Oki, M. Hosaka, J. Sugasawa, S. Kikuchi, Org.
Lett. 2007, 5557-5560.
6. R. J. Detz, S. Arevalo Heras, R. de Gelder, P. W. N. M. van
Leeuwen, H. Hiemstra, J. N. H. Reek, J. H. van Maarseveen, Org.
Lett. 2006, 8, 3227-3230.
7. a) E. M. Schuster, M. Botoshansky, M. Gandelman, Angew.
Chem. Int. Ed. 2008, 47, 4555-4558; b) E. M. Schuster, M.
Botoshansky, M. Gandelman, Organometallics 2009, 28, 7001-
7005; c) E. M. Schuster, G. Nisnevich, M. Botoshansky, M.
Gandelman, Organometallics 2009, 28, 5025-5031.
4.11.4. Pt(8b)Cl2
Colorless powder. 1H NMR (300 MHz, C6D6): δ = 5.30 - 5.76
(6H, m, CH2), 6.99-7.89 (m, 29 H, CHAr), ppm. 13C NMR (75.5
MHz, C6D6): δ = 53.3 (CH2), 56.3 (CH2), 59.8 (d, J = 4.2 Hz,
CH2), 125.3 (CAr), 127.2 (CAr), 127.7 (CAr), 128.2 (CAr), 128.6
(CAr), 128.7 (CAr), 129.2 (d, J = 12.4 Hz, CAr), 131.0 (d, J = 11.6
Hz, CAr), 131.5 (CAr), 131.9 (dd, J = 1.5 Hz, J = 8.6 Hz, CAr),
132.2 (dd, J = 1.6 Hz, J = 9.6 Hz, CAr), 133.1 (CAr), 137.8 (CAr),
142.3 (d, J = 3.3 Hz, CAr), 145.3 (d, J = 6.6 Hz, CAr), 145.6 (d, J
= 6.4 Hz, CAr), 146.3 (d, J = 12.0 Hz, CAr), 146.7 (d, J = 12.5 Hz,
8. F. Dolhem, M. J. Johansson, T. Antonsson, N. Kann, J. Comb.
Chem. 2007, 9, 477-486.
9. Y. Matano, M. Nakashima, A. Saito, H. Imahori, Org. Lett. 2009,
11, 3338-3341.
10. Q. Zhang, J. M. Takacs, Org. Lett. 2008, 10, 545-548.
11. In Ref. 7, among more than 20 phosphines-boranes also one BH3-
protected phosphine phosphite is mentioned.
12. (a) Rhodium Catalyzed Hydroformylation, van Leeuwen, P. W. N.
M.; Claver, C., Eds.; Kluver Academic Publishers: Dordrecht
Netherlands; 2000; (b) R. Franke, D. Selent, A. Börner, Chem.
Rev. 2012, 112, 5675–5732.
13. For reviews, see: a) S. Lühr, J. Holz, A. Börner, ChemCatChem
2011, 3, 1708-1730; b) Phosphorus Ligands in Asymmetric
Catalysis (Ed.: A. Börner), Wiley-VCH, Weinheim, 2008; c) N.
V. Dubrovina, I. A. Shuklov, A. Börner in Targets in Heterocyclic
Systems (Eds.: O. A. Attanasi, D. Spinelli), Royal Society of
Chemistry, Cambridge, 2008, vol. 12, 149-184. See also: a) I. A.
Shuklov, N. V. Dubrovina, E. Barsch, R. Ludwig, D. Michalik A.
Börner, Chem. Comm. 2009, 1535-1537; b) M.-N. Birkholz, N. V.
Dubrovina, H. Jiao, D. Michalik, J. Holz, R. Paciello, B. Breit, A.
Börner, Chem. Eur. J. 2007, 13, 5896-5907; c) N. V. Dubrovina, I.
A. Shuklov, M.-N. Birkholz, D. Michalik, R. Paciello, A. Börner,
Adv. Synt. Catal. 2007, 349, 2183-2187; d) N. Dubrovina, A.
Boerner, in Catalysts for Fine Chemical Synthesis (Eds.: S. M.
Roberts, J. Whittall) John Wiley&Sons Ltd., Chichester, 2007,
vol. 5, pp 89-93.
1
CAr), 31P NMR (121.5 MHz, C6D6): δ = 88.7 ppm (br. d, J(PPt)
=
=
2
1
2
5562 Hz, J(PP) = 24 Hz), 93.7 ppm (d, J(PPt) = 5542 Hz, J(PP)
24 Hz). HRMS (ESI) for C51H36Cl2N3O6P2Pt found: 1114.10878
[M+H]+, cacld. 1114.10963 [M+H]+.
HRMS (ESI) for
C51H36Cl2N3NaO6P2Pt found: 1136.09469 [M+Na]+, cacld.
1136.09157 [M+Na]+.
4.11.5. Synthesis of Pd(5b)Cl2 complex
To a stirred suspension of Pd(MeCN)2Cl2 (0.0571, 0.1 mmol)
in CH2Cl2 (1 mL) a solution of ligand 5b (0.0259 mg, 0.1 mmol)
in CH2Cl2 (2 mL) was added dropwise and the reaction mixture
was stirred for 2 h. The reaction mixture became homogeneous.
Then the solvent was evaporated and the obtained solid was dried
in vacuum. Yield was nearly quantitative. Lightly yellow
powder.
1H NMR (300 MHz, CDCl3): δ = 2.19 ( 3H, s, CH3), 4.54 (2H,
s, CH2), 5.28 (2H, (d, J = 16.8 Hz, CH2), 6.38 (2H, d, J = 8.0 Hz,
CHAr), 6.84 (2H, d, J = 7.9 Hz, CHAr), 7.14-7.62 (m, 20 H, CHAr)
ppm. 13C NMR (75.5 MHz, CDCl3): δ = 21.9 (CH3), 54.0 (CH2),
61.6 (d, J = 2.8 Hz, CH2), 125.4 (CAr), 126.3 (CAr), 127.6 (CAr),
14. For some recent examples, see: a) I. S. Mikhel, N. V. Dubrovina,
I. A. Shuklov, W. Baumann, D. Selent, H. Jiao, A. Christiansen,